liposomal doxorubicin induced hypersensitivity reaction in breast cancer patients
Showing 1 - 1 of 1
Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients Trial in Guangzhou (Blood sampling)
Recruiting
- Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
- Blood sampling
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Dec 21, 2021